152 related articles for article (PubMed ID: 14674613)
1. CNS-delivery via conjugation to biological carriers: physiological-based approaches.
Vyas SP
Prog Drug Res; 2003; 61():189-219. PubMed ID: 14674613
[No Abstract] [Full Text] [Related]
2. Overcoming barriers by local drug delivery with liposomes.
Antimisiaris SG; Marazioti A; Kannavou M; Natsaridis E; Gkartziou F; Kogkos G; Mourtas S
Adv Drug Deliv Rev; 2021 Jul; 174():53-86. PubMed ID: 33539852
[TBL] [Abstract][Full Text] [Related]
3. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
Gadhave DG; Tagalpallewar AA; Kokare CR
AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
[TBL] [Abstract][Full Text] [Related]
4. 'Retarded pharmaceuticals' assuming a clinical role.
Muggia FM
Onkologie; 2004 Oct; 27(5):437-8. PubMed ID: 15585972
[No Abstract] [Full Text] [Related]
5. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.
Ahsan F; Rivas IP; Khan MA; Torres Suarez AI
J Control Release; 2002 Feb; 79(1-3):29-40. PubMed ID: 11853916
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
7. Cationic liposomes as in vivo delivery vehicles.
Smyth Templeton N
Curr Med Chem; 2003 Jul; 10(14):1279-87. PubMed ID: 12678799
[TBL] [Abstract][Full Text] [Related]
8. Commentary: current advances and future directions for CNS delivery.
Svensson CK; Scherrmann JM
AAPS J; 2008 Dec; 10(4):587-8. PubMed ID: 19082900
[No Abstract] [Full Text] [Related]
9. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
10. Elastic liposomes as novel carriers: recent advances in drug delivery.
Hussain A; Singh S; Sharma D; Webster TJ; Shafaat K; Faruk A
Int J Nanomedicine; 2017; 12():5087-5108. PubMed ID: 28761343
[TBL] [Abstract][Full Text] [Related]
11. The anionic boron cluster (B12H11SH)2- as a means to trigger release of liposome contents.
Gabel D; Awad D; Schaffran T; Radovan D; Dărăban D; Damian L; Winterhalter M; Karlsson G; Edwards K
ChemMedChem; 2007 Jan; 2(1):51-3. PubMed ID: 17154431
[No Abstract] [Full Text] [Related]
12. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
Vlieghe P; Khrestchatisky M
Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Abbott NJ; Begley DJ
J Drug Target; 2002 Jun; 10(4):277-83. PubMed ID: 12164376
[TBL] [Abstract][Full Text] [Related]
14. Strategies for drug delivery to the central nervous system by systemic route.
Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
[TBL] [Abstract][Full Text] [Related]
15. Immunoliposomes for cancer therapy.
Kontermann RE
Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
[TBL] [Abstract][Full Text] [Related]
16. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
17. Albumin: a versatile carrier for drug delivery.
Park K
J Control Release; 2012 Jan; 157(1):3. PubMed ID: 22119742
[No Abstract] [Full Text] [Related]
18. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.
Kim KT; Lee HS; Lee JJ; Park EK; Lee BS; Lee JY; Bae JS
Future Med Chem; 2018 Nov; 10(22):2659-2674. PubMed ID: 30499740
[TBL] [Abstract][Full Text] [Related]
19. Utilizing pectin interactions for modifying drug release.
Tiwary AK; Rana V
Ther Deliv; 2016 Aug; 7(8):517-20. PubMed ID: 27444492
[No Abstract] [Full Text] [Related]
20. Therapeutic uses of antioxidant liposomes.
Stone WL; Smith M
Mol Biotechnol; 2004 Jul; 27(3):217-30. PubMed ID: 15247495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
